Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in very platinum-sensitive ovarian cancer patients: Results from a subset analysis of the CALYPSO phase III trial-Reference-Cited by-同舟云学术

Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in very platinum-sensitive ovarian cancer patients: Results from a subset analysis of the CALYPSO phase III trial

Published:2015-02 Issue:3 Volume:51 Page:352-358
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Mahner Sven,Meier Werner,du Bois Andreas,Brown Chris,Lorusso Domenica,Dell’Anna Tiziana,Cretin Jacques,Havsteen Hanne,Bessette Paul,Zeimet Alain G.,Vergote Ignace,Vasey Paul,Pujade-Lauraine Eric,Gladieff Laurence,Ferrero Annamaria

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference19 articles.

1. Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial;Lancet,2003

2. Gemcitabine plus carboplatin compared with carboplatin in patients with platinum-sensitive recurrent ovarian cancer: an intergroup trial of the AGO-OVAR, the NCIC CTG, and the EORTC GCG;Pfisterer;J Clin Oncol,2006

3. Randomized trials of combination chemotherapy (combo) versus monotherapy (mono) in relapsed ovarian carcinoma (ROC): a meta-analysis of published data;Orlando;J Clin Oncol,2007

4. Chemotherapy in advanced ovarian cancer: an overview of randomized clinical trials;Advanced Ovarian Cancer Trialists Group;Br Med J,1991

5. Chemotherapy in advanced ovarian cancer: four systematic meta-analyses of individual patient data from 37 randomized trials;Advanced Ovarian Cancer Trialists’ Group;Br J Cancer,1998

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Myelopreservation with Trilaciclib in recurrent advanced ovarian cancer: a case report;Frontiers in Oncology;2024-04-22

2. Clinicopathological Nomogram for Predicting Platinum-Resistant/Refractory Epithelial Ovarian Cancer;Indian Journal of Gynecologic Oncology;2024-04-13

3. Comparison of paclitaxel liposomes combined with carboplatin versus paclitaxel combined with carboplatin in the treatment of advanced ovarian cancer;Journal of International Medical Research;2023-09

4. Clinical observation of liposomal doxorubicin on liver and renal function in patients with breast cancer;Toxicology Research;2023-08-26

5. Pegylated liposomal doxorubicin for relapsed epithelial ovarian cancer;Cochrane Database of Systematic Reviews;2023-07-05